BGI Group (China) (CN)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
52
Publications
2045
Citations
10436
i10-index
221
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Endovascular Thrombectomy with or without Intraven... | 2020 | 809 |
Complete Response to Neoadjuvant Chemoradiotherapy... | 2005 | 515 |
CD73 promotes hepatocellular carcinoma progression... | 2019 | 249 |
Atrial natriuretic peptide in cardiovascular biolo... | 2015 | 199 |
Morbidity and Mortality of Patients Who Underwent ... | 2021 | 182 |
Phase II and Pharmacodynamic Study of the Farnesyl... | 2003 | 170 |
PCSK6-mediated corin activation is essential for n... | 2015 | 141 |
A narrative review of tumor heterogeneity and chal... | 2021 | 137 |
COVID-19 with cystic features on computed tomograp... | 2020 | 130 |
Resibufogenin suppresses colorectal cancer growth ... | 2018 | 124 |
Hao Wang is a researcher with 2045 publications and 10436 citations. They are affiliated with BGI Group (China). Their research focuses on . With an h-index of 52, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Hao Wang and 250M+ other papers.
Citations per publication by year